Hospital admission (%) | Hospital length of stay | ICU admission n (%) | ICU days | Mechanical ventilation n (%) | Ventilator days | |
---|---|---|---|---|---|---|
Median (IQR) | Median (IQR) | Median (IQR) | ||||
Polysubstance use by number of substances | ||||||
Opioid only | 13,580 (64) | 4 (3–6) | 6183 (29) | 3 (2–5) | 1457 (7) | 3 (2–7) |
Opioids + 1 substance | 14,639 (65) | 4 (2–6) | 7137 (32) | 3 (2–5) | 2489 (11) | 3 (2–7) |
Opioids + ≥ 2 substance | 15,055 (68) | 4 (2–7) | 7529 (34) | 3 (2–6) | 3286 (15) | 2 (2–7) |
p-value | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
Polysubstance use by type of substances | ||||||
Opioids only | 13,580 (64) | 4 (3–6) | 6183 (29) | 3 (2–5) | 1457 (7) | 3 (2–7) |
Opioids and alcohol | 2216 (62) | 3 (2–6) | 1161 (33) | 3 (2–5) | 372 (10) | 3 (2–6) |
Opioids and Stimulants | 4543 (64) | 4 (2–6) | 2226 (31) | 3 (2–5) | 848 (12) | 3 (2–6) |
Opioids and benzodiazepines | 3140 (66) | 5 (3–8) | 1824 (38) | 3 (2–6) | 749 (16) | 3 (2–8) |
Opioids, alcohol and benzodiazepines | 554 (64) | 5 (3–8) | 387 (45) | 3 (2–6) | 165 (19) | 2 (1–8) |
Opioids, stimulants, and benzodiazepines | 1178 (62) | 4 (3–8) | 770 (41) | 4 (7) | 416 (22) | 3 (2–7) |
p-value | 0.0032 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |